CTNM vs WYNN · $429.6M cap vs P/E 29, rev $7.14B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus Wynn Resorts Limited (WYNN) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Wynn Resorts Limited (WYNN) is a resorts & casinos company listed on NASDAQ.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported WYNN revenue for 2025-12-31 was $7.14B. Net income was $327.3M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
CTNM currently screens at market cap $429.6M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
Not investment advice. Open the CTNM and WYNN stock pages for the full models.
Not investment advice.